At Lanmage, innovation is inspired from communication. We have a deep insight into clinical requirements, focus on and listen to the voices of the medical community, explore effective solutions, ensure practicability and applicability of our solutions, and work on breakthroughs in integrating clinical and technical applications.
Lanmage invests 10% of its annual sales revenue into research and development, adheres to independent innovation, and maintains control over its core technologies. Every year, the company launches three to six new products, and each new product is designed with at least 10 patented technologies, to continuously establish new standards for medical image quality and efficiency.
Lanmage is a “National Hi-tech Enterprise”. The company’s core team is made up of experts from the first batch of technical personnel involved in medical device R&D in China. Lanmage has created numerous records in the history of many medical devices in China, consistently broken the monopoly of foreign medical enterprises, filled the gaps in many domestic technologies and promoted and led the development of medical imaging technologies in China. Lanmage has created a benchmark in the industry in terms of independent research and development.
As a medical imaging center in Shenzhen, Lanmage works closely with the government to research and explore the development of new technologies and concepts for the future. As an engineering technology research center in Shenzhen, it continues to develop new technologies through engineering approaches, and leads and drives the development of several industry regulations and standards.
of annual sales revenue spent on R&D
new products launched each year
staff with master and above degree
patents applied in each new product
First ceiling-suspended DR with independent intellectual property rights in China
First fully automated ceiling-suspended DR with independent intellectual property rights in China
First mobile DR with independent intellectual property rights in China
First dynamic DR with independent intellectual property rights in China
First Mammography System for TOMO 3D and aspiration biopsy technologies with independent intellectual property rights in China
First batch of color ultrasound diagnostic systems in China